Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

Friday Links

Posted on July 14, 2023July 14, 2023 by John C. Goodman
  • We have been advocating OTC birth control for years.
  • Adverse selection problems in insurance markets go away if people must insure by household rather than as individuals. At least in Pakistan.
  • Is your doctor employed by a private equity firm? (NYT)
  • AARP Represents Health Insurers, Not Seniors
  • Is compression of morbidity being reversed? Considering 300 diseases in the USA from 1990 vs. 2017, health span (health-adjusted life expectancy) grew by 2 years, but life expectancy grew by 3 years.
  • The Health Care Blog goes wacko: “The greatest health equity threat to Medicaid – and Medicare – beneficiaries is the climate crisis.”
+

Thursday Links

Posted on July 13, 2023July 12, 2023 by John C. Goodman
  • Generic drug prices are falling. That’s good news for consumers unless the drug is not available.
  • Study: China’s New Cooperative Medical Scheme has saved lives, increased life expectancy.
  • Poland experienced five decades of a planned economy, followed by three decades of market orientation. The market is better.
  • Pre Obamacare, Did Health Insurance Companies Refuse to Insure a Lot of People?
  • Why do so many private schools look just like public schools?
+

Wednesday Links

Posted on July 12, 2023July 12, 2023 by John C. Goodman
  • California considers affirmative action for prison sentences.
  • Arnold Kling against marijuana.
  • “We propose a new priority review voucher program to incentivize competition in limited-competition, small molecule generics markets.”
  • Study: “We estimate that the recently proposed US price controls on drugs in the US would raise health care spending by $50.8 billion over a 20-year period.”
+

Monday Links

Posted on July 10, 2023July 10, 2023 by John C. Goodman
  • British patients are not grateful for the free care they receive from the NHS.
  • Pfizer: antibiotic shortage could worsen syphilis epidemic. (NYT)
  • Should you worry about “forever chemicals” in your drinking water?
  • Turley to Zuckerberg: “Release the Facebook Files.”
  • Evidence lacking that dietary supplements sharpen the mind.
  • Negative results from Portugal’s experiment with decriminalization of drug use.
  • Another article on drug shortages that fails to ask the obvious question: Why isn’t there a shortage of aspirin?
+
  • Previous
  • 1
  • …
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • …
  • 243
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 43 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom